PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Apr-2022 Weekly Life Science News Round-Up: 28th March – 1st April PharmiWeb
01-Apr-2022 Novel nuclear microRNA is being developed for the treatment of cardiovascular disease RNatives
01-Apr-2022 Innovative Trials suspends services in Russia in response to Ukraine war Innovative Trials
01-Apr-2022 UCB Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting UCB
01-Apr-2022 Asceneuron Publishes Pioneering Preclinical Efficacy Data on its Novel Clinical Molecule ASN90 in Both Alzheimer’s and Parkinson’s Disease Models Asceneuron
01-Apr-2022 EUROAPI listing on Euronext Paris expected on May 6, 2022 Sanofi
01-Apr-2022 Freeline Reports Full Year 2021 Financial Results and Business Highlights Freeline Therapeutics Holdings plc
01-Apr-2022 Labcorp Renews Strategic Partnership with Medidata to Provide Suite of Clinical Trial Technologies and Services Medidata
01-Apr-2022 Hyloris Launches Equity Offering by Means of a Private Placement Via an Accelerated Bookbuild Offering Hyloris Pharmaceuticals SA
01-Apr-2022 Healthtech startup accelerating genetic disease research raises $11M in Series A funding round Sano Genetics
01-Apr-2022 Future investment plan - HCS Pharma announces the success of the ONCO3D project to discover new anti-cancer therapies HCS Pharma
01-Apr-2022 ViiV Healthcare announces US FDA approval of Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV ViiV Healthcare
01-Apr-2022 HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-Resistant Depression (TRD), suggesting antidepressant efficacy and showing Placebo-Level Dissociative Side Effects in Phase 2 oral prolonged-release Ketamine (KET01) Study HMNC Brain Health
01-Apr-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 21 Million (news with additional features) Vivoryon Therapeutics N.V.
01-Apr-2022 Relief Therapeutics Announces that its Subsidiary was Issued a Swiss Patent Entitled 'Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis' Relief Therapeutics Holding SA
01-Apr-2022 Spexis publishes invitation to Annual General Meeting 2022 Spexis AG
01-Apr-2022 Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19 Relief Therapeutics Holding SA
01-Apr-2022 PolyPeptide publishes invitation to the annual General Meeting 2022 PolyPeptide Group
01-Apr-2022 Straumann Group announces new Executive Management Board members to support growth strategy Straumann Holding AG
31-Mar-2022 Iktos Announces a Collaboration With Ono in Artificial Intelligence for New Drug Design Iktos